澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

RACE ONCOLOGY LTD

2.120

+0.0200.95%

成交量：1.60萬

成交額：3.36萬

市值：4.16億

市盈率：-39.22

高：2.130

開：2.120

低：2.080

收：2.100

52周最高：4.900

52周最低：1.180

股本：1.96億

流通股本：1.21億

量比：0.26

換手率：0.01%

股息：- -

股息率：- -

每股收益(TTM):-0.054

每股收益(LYR):-0.028

淨資產收益率：-42.40%

總資產收益率：-21.91%

市淨率：17.64

市盈率(LYR):-76.36

資料載入中...

總覽公司新聞資訊公告

概念

醫藥生物股+2.85%

資金流向

資金流入：

資金流出：

新聞資訊

Racura Oncology通過配售與跟投及獎勵期權資金，籌集3120萬美元支持RC220臨床開發

瑞庫拉腫瘤學宣佈CPACS臨床試驗獲得安全審查委員會積極推薦

Racura Oncology 宣佈Cpacs臨床試驗獲安全審查委員會積極建議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/RAC.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RAC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAC.AU\",,,,,undefined,":{"symbol":"RAC.AU","market":"AU","secType":"STK","nameCN":"RACE ONCOLOGY LTD","latestPrice":2.12,"timestamp":1787638320000,"preClose":2.1,"halted":0,"volume":15972,"delay":0,"changeRate":0.009523809523809532,"nameEN":"RACE ONCOLOGY LTD","floatShares":121205750,"shares":196068940,"eps":-0.054053,"marketStatus":"未開盤","change":0.02,"latestTime":"08-25 16:12:00 AEST","open":2.12,"high":2.13,"low":2.08,"amount":33637,"amplitude":0.02381,"askPrice":2.12,"askSize":4988,"bidPrice":2.08,"bidSize":460,"shortable":3,"etf":0,"ttmEps":-0.054053,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.1,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.261791,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RAC.AU","preClose":2.1,"auctionPrice":2.12,"auctionVolume":12,"auction":3,"marketStatus":"盘后竞价","timestamp":1787638083602}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAC.AU\",,,,,undefined,":{"symbol":"RAC.AU","floatShares":121205750,"roa":"-21.91%","roe":"-42.40%","lyrEps":-0.027765,"volumeRatio":0.261791,"shares":196068940,"dividePrice":0,"high":2.13,"amplitude":0.02381,"preClose":2.1,"low":2.08,"week52Low":1.18,"pbRate":"17.64","psRate":"119.56","week52High":4.9,"institutionHeld":0,"latestPrice":2.12,"committee":-0.831131,"eps":-0.054053,"divideRate":0,"volume":15972,"delay":0,"ttmEps":-0.054053,"open":2.12,"prevYearClose":2.73,"prevWeekClose":2.1,"prevMonthClose":1.95,"prevQuarterClose":2.22,"fiveDayClose":2.12,"twentyDayClose":2.04,"sixtyDayClose":2.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAC.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAC.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1168425417","title":"Racura Oncology通過配售與跟投及獎勵期權資金，籌集3120萬美元支持RC220臨床開發","url":"https://stock-news.laohu8.com/highlight/detail?id=1168425417","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168425417?lang=zh_tw&edition=fundamental","pubTime":"2026-06-04 06:53","pubTimestamp":1780527198,"startTime":"0","endTime":"0","summary":"Racura Oncology宣布，公司通过股权配售，并结合跟投与奖励期权计划所获资金，成功筹集了总计3120万美元。这笔资金将专项用于支持其候选药物RC220的临床开发项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149868178","title":"瑞庫拉腫瘤學宣佈CPACS臨床試驗獲得安全審查委員會積極推薦","url":"https://stock-news.laohu8.com/highlight/detail?id=1149868178","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149868178?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 19:23","pubTimestamp":1778844180,"startTime":"0","endTime":"0","summary":"瑞库拉肿瘤学有限公司宣布，其正在进行的CPACS临床试验获得了安全审查委员会的积极推荐。\n瑞库拉肿瘤学有限公司指出，在第一队列中，单独使用RC220或与多柔比星联合使用均未发现安全性问题。\n瑞库拉肿瘤学有限公司表示，将在80毫克/平方米的RC220剂量水平上，启动第二队列患者的筛选工作。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108465491","title":"Racura Oncology 宣佈Cpacs臨床試驗獲安全審查委員會積極建議","url":"https://stock-news.laohu8.com/highlight/detail?id=1108465491","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108465491?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 19:08","pubTimestamp":1778843295,"startTime":"0","endTime":"0","summary":"Racura Oncology宣布，其正在进行的Cpacs临床试验已获得安全审查委员会的积极建议，标志着该研究的一个重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RAC.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"醫藥生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.0285}]}}